{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:54:50Z","timestamp":1775278490073,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T00:00:00Z","timestamp":1233964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s12031-009-9181-z","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T07:52:48Z","timestamp":1233993168000},"page":"211-219","source":"Crossref","is-referenced-by-count":24,"title":["A Novel Anti-Parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice"],"prefix":"10.1007","volume":"39","author":[{"given":"Ryohei","family":"Yano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,7]]},"reference":[{"key":"9181_CR1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"J. E. Ahlskog","year":"2001","unstructured":"Ahlskog, J. E., & Munenter, M. D. (2001). Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Movement Disorders, 16, 448\u2013458. doi: 10.1002\/mds.1090 .","journal-title":"Movement Disorders"},{"key":"9181_CR2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02944-4","volume":"918","author":"T. Araki","year":"2001","unstructured":"Araki, T., Kumagai, T., Tanaka, K., et al. (2001). Neuroprotective effect of riluzole in MPTP-treated mice. Brain Research, 918, 176\u2013181. doi: 10.1016\/S0006-8993(01)02944-4 .","journal-title":"Brain Research"},{"key":"9181_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neures.2007.10.002","volume":"60","author":"M. Asanuma","year":"2008","unstructured":"Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J., et al. (2008). Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation. Neuroscience Research, 60, 106\u2013113. doi: 10.1016\/j.neures.2007.10.002 .","journal-title":"Neuroscience Research"},{"key":"9181_CR4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W. Dauer","year":"2003","unstructured":"Dauer, W., & Przedborski, S. (2003). Parkinson\u2019s disease: Mechanisms and models. Neuron, 39, 889\u2013909. doi: 10.1016\/S0896-6273(03)00568-3 .","journal-title":"Neuron"},{"key":"9181_CR5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-291X(90)90498-C","volume":"170","author":"E. Hasegawa","year":"1990","unstructured":"Hasegawa, E., Takeshige, K., Oishi, T., Murai, Y., & Minakami, S. (1990). 1-Methylphenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochemical and Biophysical Research Communications, 170, 1049\u20131055. doi: 10.1016\/0006-291X(90)90498-C .","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9181_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(94)90704-8","volume":"257","author":"T. Hayakawa","year":"1994","unstructured":"Hayakawa, T., Higuchi, Y., Nigami, H., & Hattori, H. (1994). Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect. European Journal of Pharmacology, 257, 131\u2013136. doi: 10.1016\/0014-2999(94)90704-8 .","journal-title":"European Journal of Pharmacology"},{"key":"9181_CR7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","volume":"311","author":"R. E. Heikkila","year":"1984","unstructured":"Heikkila, R. E., Manzino, L., Cabbat, E. S., & Duvosion, R. C. (1984). Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine by monoamine oxidase inhibitors. Nature, 311, 467\u2013469. doi: 10.1038\/311467a0 .","journal-title":"Nature"},{"key":"9181_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.mad.2004.12.004","volume":"126","author":"T. Himeda","year":"2005","unstructured":"Himeda, T., Mizuno, K., Kato, H., & Araki, T. (2005). Effects of age on immunohistochemical changes in the mouse hippocampus. Mechanisms of Ageing and Development, 126, 673\u2013677. doi: 10.1016\/j.mad.2004.12.004 .","journal-title":"Mechanisms of Ageing and Development"},{"key":"9181_CR9","first-page":"1581","volume":"32","author":"T. Ito","year":"1982","unstructured":"Ito, T., Yamaguchi, T., Miyazaki, H., et al. (1982). Pharmacokinetic studies of AD-810, a new antiepileptic compound. Phase I trials. Arzneimittel-Forschung, 32, 1581\u20131586.","journal-title":"Arzneimittel-Forschung"},{"key":"9181_CR10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1528-1157.2000.tb00312.x","volume":"41","author":"M. Komatsu","year":"2000","unstructured":"Komatsu, M., Hiramatsu, M., & Willmore, L. J. (2000). Zonisamide reduces the increase in a 8-hydroxy-2\u2019-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats. Epilepsia, 41, 1091\u20131094. doi: 10.1111\/j.1528-1157.2000.tb00312.x .","journal-title":"Epilepsia"},{"key":"9181_CR11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0197-4580(02)00085-4","volume":"24","author":"R. Kurosaki","year":"2003","unstructured":"Kurosaki, R., Akasaka, M., Michimata, M., et al. (2003). Effect of Ca2+ antagonists on motor activity and the dopaminergic system I aged mice. Neurobiology of Aging, 24, 315\u2013319. doi: 10.1016\/S0197-4580(02)00085-4 .","journal-title":"Neurobiology of Aging"},{"key":"9181_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2004.05.007","volume":"15","author":"R. Kurosaki","year":"2005","unstructured":"Kurosaki, R., Muramatsu, Y., Kato, H., et al. (2005). Effect of angiotensin-converting enzyme inhibitor perindpril on iterneurons in MPTP-treated mice. European Neuropsychopharmacology, 15, 57\u201367. doi: 10.1016\/j.euroneuro.2004.05.007 .","journal-title":"European Neuropsychopharmacology"},{"key":"9181_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(97)00097-1","volume":"30","author":"A. Mori","year":"1998","unstructured":"Mori, A., Noda, Y., & Packer, L. (1998). The anticonvulsant zonisamide scavenges free radicals. Epilepsy Research, 30, 153\u2013158. doi: 10.1016\/S0920-1211(97)00097-1 .","journal-title":"Epilepsy Research"},{"key":"9181_CR14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00702-003-0021-y","volume":"110","author":"Y. Muramatsu","year":"2003","unstructured":"Muramatsu, Y., Kurosaki, R., Watanabe, H., et al. (2003). Cerebral alterations in a MPTP-mouse model of Parkinson\u2019s disease-an immunocytochemical study. Journal of Neural Transmission, 110, 1129\u20131144. doi: 10.1007\/s00702-003-0021-y .","journal-title":"Journal of Neural Transmission"},{"key":"9181_CR15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2174\/1381612043453180","volume":"10","author":"M. Murata","year":"2004","unstructured":"Murata, M. (2004). Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson\u2019s disease. Current Pharmaceutical Design, 10, 687\u2013693. doi: 10.2174\/1381612043453180 .","journal-title":"Current Pharmaceutical Design"},{"key":"9181_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","volume":"68","author":"M. Murata","year":"2007","unstructured":"Murata, M., Hasegawa, K., & Kanazawa, I. (2007). Zonisamide improves motor function in Parkinson\u2019s disease. Neurology, 68, 45\u201350. doi: 10.1212\/01.wnl.0000250236.75053.16 .","journal-title":"Neurology"},{"issue":"Suppl. 4","key":"9181_CR17","first-page":"iv23","volume":"252","author":"N. Ogawa","year":"2005","unstructured":"Ogawa, N., Asanuma, M., Miyazaki, I., Diaz-Corrales, F., & Miyoshi, K. (2005). L-DOPA treatment from the viewpoint of neuroprotection: Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson\u2019s disease. Journal of Neurology, 252(Suppl. 4), iv23\u2013iv31. doi: 10.1007\/s00415-005-4006-7 .","journal-title":"Journal of Neurology"},{"key":"9181_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","volume":"22","author":"M. Okada","year":"1995","unstructured":"Okada, M., Kaneko, S., Hirano, T., et al. (1995). Effects of zonisamide on dopaminergic system. Epilepsy Research, 22, 193\u2013205. doi: 10.1016\/0920-1211(95)00078-X .","journal-title":"Epilepsy Research"},{"key":"9181_CR19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0920-1211(89)90041-7","volume":"3","author":"D. Rock","year":"1989","unstructured":"Rock, D., MacDonald, R., & Taylor, C. (1989). Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisaimde (AD 810, CI 912), a novel anticonvulsant. Epilepsy Research, 3, 138\u2013143. doi: 10.1016\/0920-1211(89)90041-7 .","journal-title":"Epilepsy Research"},{"key":"9181_CR20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(87)90168-5","volume":"413","author":"C. Schauf","year":"1987","unstructured":"Schauf, C. (1987). Zonisamide enhances slow sodium inactivation in Myxicola. Brain Research, 413, 185\u2013188. doi: 10.1016\/0006-8993(87)90168-5 .","journal-title":"Brain Research"},{"key":"9181_CR21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0006-8993(96)01271-1","volume":"749","author":"K. Sriram","year":"1997","unstructured":"Sriram, K., Pai, K. S., Boyd, M. R., & Ravindranath, V. (1997). Evidence for generation of oxidative stress in brain by MPTP: In vitro and in vivo studies in mice. Brain Research, 749, 44\u201352. doi: 10.1016\/S0006-8993(96)01271-1 .","journal-title":"Brain Research"},{"key":"9181_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-1211(92)90087-A","volume":"12","author":"S. Suzuki","year":"1992","unstructured":"Suzuki, S., Kawakami, K., Nishimura, S., et al. (1992). Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Research, 12, 21\u201327. doi: 10.1016\/0920-1211(92)90087-A .","journal-title":"Epilepsy Research"},{"key":"9181_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.mad.2007.01.002","volume":"128","author":"A. Tanaka","year":"2007","unstructured":"Tanaka, A., Watanabe, Y., Kato, H., & Araki, T. (2007). Immunohistochemical changes to ageing in the mouse hippocampus and subventicular zone. Mechanisms of Ageing and Development, 128, 303\u2013310. doi: 10.1016\/j.mad.2007.01.002 .","journal-title":"Mechanisms of Ageing and Development"},{"key":"9181_CR24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","volume":"61","author":"K. F. Tipton","year":"1993","unstructured":"Tipton, K. F., & Singer, T. P. (1993). Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. Journal of Neurochemistry, 61, 1191\u20131206. doi: 10.1111\/j.1471-4159.1993.tb13610.x .","journal-title":"Journal of Neurochemistry"},{"key":"9181_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00702-008-0019-6","volume":"115","author":"H. Yokoyama","year":"2008","unstructured":"Yokoyama, H., Takagi, S., Watanabe, Y., Kato, H., & Araki, T. (2008). Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. Journal of Neural Transmission, 115, 831\u2013842. doi: 10.1007\/s00702-008-0019-6 .","journal-title":"Journal of Neural Transmission"},{"key":"9181_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60277-9","volume":"31","author":"M. J. Zigmond","year":"1989","unstructured":"Zigmond, M. J., & Stricker, E. M. (1989). Animals models of parkinsonism using selective neurotoxins: Clinical and basic implications. International Review of Neurobiology, 31, 1\u20139. doi: 10.1016\/S0074-7742(08)60277-9 .","journal-title":"International Review of Neurobiology"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-009-9181-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-009-9181-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-009-9181-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:19:20Z","timestamp":1559441960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-009-9181-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,7]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9181"],"URL":"https:\/\/doi.org\/10.1007\/s12031-009-9181-z","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,7]]}}}